For the millions suffering in silence from back pain, GLP-1 therapies offer not just symptom relief, but the possibility of a more active, less painful life
Preservative-free products do not contain added preservatives and may be preferred for some patients with sensitivities
Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events (MACE) in adults with overweight or obesity and established cardiovascular disease
While many candidates remain in preclinical development, several agents such as Fevipiprant (DP2 antagonist) and Ensifentrine (PDE3/4 inhibitor) have advanced to late-stage clinical trials, potentially offering new therapeutic options for severe and therapy-resistant asthma
If the side effects at a higher dose are too intense, the standard medical advice is usually to stay at the lower, more tolerable dose for another month rather than trying to split a higher dose
En este contexto, un ensayo clnico realizado por la compaa Novo Nordisk en su fase 3 ha arrojado resultados prometedores sobre la eficacia de este frmaco en la reduccin de peso
